FDA Approved: GIVLAARI — Supplemental Application (Alnylam Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for GIVLAARI (givosiran) filed by Alnylam Pharmaceuticals, updating the drug's labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Porphyria

Drugs mentioned

• GIVLAARI (Givosiran)

Snippet

SUPPL AP for GIVLAARI (GIVOSIRAN SODIUM)